Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.

导出原文传递

翻译打印收藏纠错

第一作者： Emiliano,Peña-Altamira

第一单位： a Department of Pharmacy and Biotechnology , University of Bologna , Bologna , Italy.

作者： Emiliano,Peña-Altamira ^[1] ; Federica,Prati ^[1] ; Francesca,Massenzio ^[1] ; Marco,Virgili ^[1] ; Antonio,Contestabile ^[1] ; Maria Laura,Bolognesi ^[1] ; Barbara,Monti ^[1]

作者单位： a Department of Pharmacy and Biotechnology , University of Bologna , Bologna , Italy. ^[1]

关键词 Drug targets M2 and M1 phenotypes immunomodulation microglia neurodegenerative diseases

主题词动物(Animals);消炎药(Anti-Inflammatory Agents);人类(Humans);免疫调节(Immunomodulation);小神经胶质细胞(Microglia);神经变性疾病(Neurodegenerative Diseases)

DOI 10.1517/14728222.2016.1121237

PMID 26568363

发布时间 2016-12-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览12

Expert opinion on therapeutic targets

2016年20卷5期

627-40页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.

Expert opinion on therapeutic targets

相似文献

Expert opinion on therapeutic targets

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.

Expert opinion on therapeutic targets

相似文献

Expert opinion on therapeutic targets

相关期刊

检索历史清除